Clinical Activity and Safety of Cediranib and Olaparib Combination in Patients with Metastatic Pancreatic Ductal Adenocarcinoma without BRCA Mutation

Joseph W. Kim, Dana B. Cardin, Ulka N. Vaishampayan, Shumei Kato, Steven R. Grossman, Peter M. Glazer, Yu Shyr, S. Percy Ivy, Patricia M. LoRusso

研究成果: Article › 同行評審

8 引文 斯高帕斯（Scopus）

指紋

深入研究「Clinical Activity and Safety of Cediranib and Olaparib Combination in Patients with Metastatic Pancreatic Ductal Adenocarcinoma without BRCA Mutation」主題。共同形成了獨特的指紋。

Medicine & Life Sciences